Gabriel Sardi is a Cardiology physician. OpenAlex indexes 95 publications with 816 citations (h-index 14).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
500 Cadmus Ln
Suite 207
Easton, MD 216014094
Telephone
410-822-5571Registry record last updated 10 May 2017.
Industry payments
26 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Shockwave Medical, IncProgram year20253 payments
- Edwards Lifesciences CorporationProgram year20252 payments
- ZOLL Services LLC (A/K/A ZOLL LifeCor Corp)Program year20255 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
83.4%Statin23.7%Rosuvastatin Calcium53%Atorvastatin Calcium47%Part D≥56 patientsBeta blocker17.1%Metoprolol Succinate64%Carvedilol26%Metoprolol Tartrate10%Part D<11 patients+ 11 more classes in this area
Blood & clotting
12.3%P2Y12 inhibitor6.8%Clopidogrel53%Brilinta47%Part D<11 patientsFactor Xa inhibitor5.6%Eliquis100%Part D≥17 patientsMetabolism & gastrointestinal
4.3%SGLT2 inhibitor4.3%Jardiance100%Part D≥11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Chronic Renal Insufficiency and Coronary Chronic Total Occlusion: A Most Perilous Combination
Cardiovascular revascularization medicine
2022 - With End-Stage Renal Disease (ESRD), Are the Hungriest Being Served Last?
Cardiovascular revascularization medicine
2020 - Improved Renal Function: A Novel Prognostic Parameter After PCI?
Cardiovascular revascularization medicine
2020 - Drug-eluting stents in patients on chronic hemodialysis: Paclitaxel-eluting stents vs. limus-eluting stents
Cardiovascular revascularization medicine
2014
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this institution yet.
Deepak Bhatt, MD
Icahn School of Medicine at Mount Sinai
Harlan Krumholz, MD
Yale School of Medicine
Scott Solomon, MD
Brigham and Women's Hospital
Eric Topol, MD
Scripps Research Institute (Scripps Research)
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”